ijms-logo

Journal Browser

Journal Browser

Mesenchymal Stem Cells in Health and Disease 3.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (30 August 2024) | Viewed by 3794

Special Issue Editor


E-Mail Website
Guest Editor
Center for Research on Harmful Effects of Biological and Chemical Hazards, Departments of Genetics, Microbiology and Immunology, University of Kragujevac, 34000 Kragujevac, Serbia
Interests: mesenchymal stem cells; T lymphocytes; flow cytometry; immunity; immunology of infectious diseases; immunomodulation; molecular immunology; inflammation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Mesenchymal stem cells (MSCs) are self-renewable, adult stem cells that reside in almost all postnatal tissue and organs, where they regulate homeostasis and promote the repair and regeneration of injured tissues. Damage-associated molecular patterns and alarmins, released from injured cells, induce the activation of MSCs, which, in turn, prevent the apoptosis of uninjured parenchymal cells and stimulate their survival and proliferation. MSCs suppress the effector functions of inflammatory neutrophils, monocytes, T lymphocytes, and natural killer (NK) and natural killer T (NKT) cells, and promote the generation and expansion of immunosuppressive T regulatory cells (Tregs), leading to the alleviation of an ongoing inflammation. Additionally, MSCs induce neoangiogenesis and promote the homing of alternatively activated macrophages and tolerogenic dendritic cells (DCs) to the inflamed tissues, where these immunoregulatory cells enhance the endogenous healing process.

MSC-derived extracellular vesicles (MSC-EVs) have shown beneficial therapeutic effects similar to those observed after the transplantation of their parental cells. MSC-EVs, distributed via biological fluids, can easily penetrate through the tissues and reach the target cells (even distant ones), enabling both paracrine and endocrine effects. MSC-EVs rapidly diffuse throughout the tissue, successfully delivering trophic and immunomodulatory factors that results in the attenuation of tissue injury and inflammation.

Therefore, due to their immunosuppressive and regenerative properties, MSCs and their EVs have been considered new potential therapeutic agents in the treatment of inflammatory and degenerative diseases.

This Special Issue calls for original research and review articles that may provide novel insights regarding the molecular and cellular mechanisms that are responsible for MSC-based effects and also current knowledge and future perspectives regarding the therapeutic application of MSCs and MSC-EVs in experimental and clinical settings.

Prof. Dr. Vladislav Volarevic
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesenchymal stem cells
  • extracellular vesicles
  • stem cells
  • exosome
  • MSC-EVs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issues

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 4594 KiB  
Article
Comparative Analysis of Serum and Serum-Free Medium Cultured Mesenchymal Stromal Cells for Cartilage Repair
by Meiqi Kang, Yanmeng Yang, Haifeng Zhang, Yuan Zhang, Yingnan Wu, Vinitha Denslin, Rashidah Binte Othman, Zheng Yang and Jongyoon Han
Int. J. Mol. Sci. 2024, 25(19), 10627; https://doi.org/10.3390/ijms251910627 - 2 Oct 2024
Cited by 3 | Viewed by 1942
Abstract
Mesenchymal stromal cells (MSCs) are promising candidates for cartilage repair therapy due to their self-renewal, chondrogenic, and immunomodulatory capacities. It is widely recognized that a shift from fetal bovine serum (FBS)-containing medium toward a fully chemically defined serum-free (SF) medium would be necessary [...] Read more.
Mesenchymal stromal cells (MSCs) are promising candidates for cartilage repair therapy due to their self-renewal, chondrogenic, and immunomodulatory capacities. It is widely recognized that a shift from fetal bovine serum (FBS)-containing medium toward a fully chemically defined serum-free (SF) medium would be necessary for clinical applications of MSCs to eliminate issues such as xeno-contamination and batch-to-batch variation. However, there is a notable gap in the literature regarding the evaluation of the chondrogenic ability of SF-expanded MSCs (SF-MSCs). In this study, we compared the in vivo regeneration effect of FBS-MSCs and SF-MSCs in a rat osteochondral defect model and found poor cartilage repair outcomes for SF-MSCs. Consequently, a comparative analysis of FBS-MSCs and SF-MSCs expanded using two SF media, MesenCult™-ACF (ACF), and Custom StemPro™ MSC SFM XenoFree (XF) was conducted in vitro. Our results show that SF-expanded MSCs constitute variations in morphology, surface markers, senescence status, differentiation capacity, and senescence/apoptosis status. Highly proliferative MSCs supported by SF medium do not always correlate to their chondrogenic and cartilage repair ability. Prior determination of the SF medium’s ability to support the chondrogenic ability of expanded MSCs is therefore crucial when choosing an SF medium to manufacture MSCs for clinical application in cartilage repair. Full article
(This article belongs to the Special Issue Mesenchymal Stem Cells in Health and Disease 3.0)
Show Figures

Graphical abstract

21 pages, 5041 KiB  
Article
Prevention of Transition from Acute Kidney Injury to Chronic Kidney Disease Using Clinical-Grade Perinatal Stem Cells in Non-Clinical Study
by Agne Gryguc, Justinas Maciulaitis, Lukas Mickevicius, Arvydas Laurinavicius, Neringa Sutkeviciene, Ramune Grigaleviciute, Vilma Zigmantaite, Romaldas Maciulaitis and Inga Arune Bumblyte
Int. J. Mol. Sci. 2024, 25(17), 9647; https://doi.org/10.3390/ijms25179647 - 6 Sep 2024
Viewed by 1518
Abstract
Acute kidney injury (AKI) is widely recognized as a precursor to the onset or rapid progression of chronic kidney disease (CKD). However, there is currently no effective treatment available for AKI, underscoring the urgent need for the development of new strategies to improve [...] Read more.
Acute kidney injury (AKI) is widely recognized as a precursor to the onset or rapid progression of chronic kidney disease (CKD). However, there is currently no effective treatment available for AKI, underscoring the urgent need for the development of new strategies to improve kidney function. Human placental mesenchymal stromal cells (hpMSCs) were isolated from donor placentas, cultured, and characterized with regard to yield, viability, flow cytometry, and potency. To mimic AKI and its progression to CKD in a rat model, a dedicated sensitive non-clinical bilateral kidney ischemia-reperfusion injury (IRI) model was utilized. The experimental group received 3 × 105 hpMSCs into each kidney, while the control group received IRI and saline and the untreated group received IRI only. Urine, serum, and kidney tissue samples were collected over a period of 28 days. The hpMSCs exhibited consistent yields, viability, and expression of mesenchymal lineage markers, and were also shown to suppress T cell proliferation in a dose-dependent manner. To ensure optimal donor selection, manufacturing optimization, and rigorous quality control, the rigorous Good Manufacturing Practice (GMP) conditions were utilized. The results indicated that hpMSCs increased rat survival rates and improved kidney function by decreasing serum creatinine, urea, potassium, and fractionated potassium levels. Furthermore, the study demonstrated that hpMSCs can prevent the initial stages of kidney structural fibrosis and improve kidney function in the early stages by mitigating late interstitial fibrosis and tubular atrophy. Additionally, a robust manufacturing process with consistent technical parameters was established. Full article
(This article belongs to the Special Issue Mesenchymal Stem Cells in Health and Disease 3.0)
Show Figures

Figure 1

Back to TopTop